Related Experiment Video
Updated: May 2, 2026

15:31
MISSION esiRNA for RNAi Screening in Mammalian Cells
Published on: May 12, 2010
16.3K
A Cell-Based Screening Assay for rRNA-Targeted Drug Discovery
Sandra Story1, Dev P Arya2,1
1NUBAD, LLC, Greenville, South Carolina 29605, United States.
ACS Infectious Diseases
|November 12, 2024
Summary
Researchers developed a novel fluorescent assay to rapidly screen for new antibiotics targeting bacterial RNA. This high-throughput method effectively measures aminoglycoside binding affinity in living cells, aiding drug discovery efforts against antibiotic resistance.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Bacterial antibiotic resistance is a growing global health threat, necessitating new drug development strategies.
- Current drug discovery methods face challenges in rapidly screening novel antimicrobial compounds in living cells.
- Fluorescent probes offer a promising avenue for visualizing and quantifying drug-target interactions within microorganisms.
Purpose of the Study:
- To develop and optimize a cell-based fluorescent assay for rapid screening of aminoglycoside antibiotic candidates.
- To characterize aminoglycoside binding affinities to bacterial ribosomal RNA (rRNA) in living cells.
- To evaluate the assay's performance for both planktonic bacteria and biofilms.
Main Methods:
- A fluorescent aminoglycoside probe was designed to accumulate in *Escherichia coli* cells.
- Competitive displacement of the fluorescent probe by potential drug candidates was measured via fluorescence intensity.
- Assay optimization focused on signal-to-background ratio, reliability, and high-throughput screening compatibility.
- The assay's sensitivity and performance were assessed using various known aminoglycosides and against planktonic cells and biofilms.
Main Results:
- The fluorescent probe's accumulation and displacement correlated with aminoglycoside binding affinity to the 16S rRNA A-site.
- A clear hierarchy of binding affinities was established for tested aminoglycosides, with neomycin showing the highest affinity.
- The assay demonstrated high sensitivity and excellent performance (average Z' factor of 0.80 for planktonic cells, 0.61 for biofilms).
Conclusions:
- The developed cell-based fluorescent assay enables rapid, direct characterization of aminoglycoside binding in living bacterial cells.
- This assay holds significant potential for high-throughput screening and identification of novel ribosomal binding antibiotics.
- The assay's effectiveness in both planktonic and biofilm states highlights its utility in diverse physiological contexts for combating antibiotic resistance.

